MTOR and gastric cancer: A formononetin-coumarin hybrid compound, derived from formononetin, demonstrated anti-proliferative, tumor growth inhibitory, and anti-migratory properties against SGC7901 gastric cancer cells by modulating the Wnt/β-catenin and Akt/mTOR pathways (Yao et al. 2019).